Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...